speb/financial-data huggingface dataset:
Financial ratios for NAQ.DE — quarterly report dated 2025-03-31
Total revenue: 2096000000
Gross profit: 816000000
Operating income: 576000000
Net income: 395000000
Capital expenditures: 49000000
Operating cash flow: 663000000
Depreciation & amortization: 156000000
Net tangible assets: -9463000000
Owner earnings: 502000000
Return on net tangible assets (%): -5.304871605199197
Capex to operating income (%): 8.506944444444445
Buffett classification: The Great
Stock price: 74.09782608695652
P/E ratio: 26.21456208670886
Shares outstanding: 558977372
Book value: 11555000000
P/B ratio: 3.5845095713543915
Market cap (USD): 41419008097
Debt to equity: 0.8411077455646906
Current ratio: 0.9808054196462176
Quick ratio: 0.9808054196462176
Effective tax rate (%): 19.057377049180328
Interest coverage ratio: 6.260869565217392
COGS to revenue (%): 61.06870229007634
SG&A to revenue (%): 4.007633587786259
Free cash flow (dilution-adjusted): 579000000
Buyback yield (%): 0.27765029942455216
Retained earnings: 8658000000
Receivables turnover: 2.125760649087221
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5401305344858
FCF margin (%): 27.62404580152672
Rule of 40 score: 27.62404580152672
Financial ratios for NAQ.DE — quarterly report dated 2025-06-30
Total revenue: 2101000000
Gross profit: 861000000
Operating income: 597000000
Net income: 452000000
Capital expenditures: 59000000
Operating cash flow: 746000000
Depreciation & amortization: 158000000
Net tangible assets: -9258000000
Owner earnings: 551000000
Return on net tangible assets (%): -5.951609418880968
Capex to operating income (%): 9.882747068676718
Buffett classification: The Great
Stock price: 87.96470588235294
P/E ratio: 58.05227877552608
Shares outstanding: 558977372
Book value: 11818000000
P/B ratio: 4.160626173876341
Market cap (USD): 49170280122.87059
Debt to equity: 0.814943306820105
Current ratio: 0.9601671672978973
Quick ratio: 0.9601671672978973
Effective tax rate (%): 17.51824817518248
Interest coverage ratio: 6.489130434782608
COGS to revenue (%): 59.06711089957163
SG&A to revenue (%): 5.045216563541171
Free cash flow (dilution-adjusted): 641000000
Buyback yield (%): 0.2033748836697942
Retained earnings: 8955000000
Receivables turnover: 2.3448660714285716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6269471090381065
FCF margin (%): 30.50928129462161
Revenue growth (%): 0.2385496183206107
Rule of 40 score: 30.74783091294222
Financial ratios for NAQ.DE — quarterly report dated 2025-09-30
Total revenue: 1958000000
Gross profit: 870000000
Operating income: 607000000
Net income: 423000000
Capital expenditures: 69000000
Operating cash flow: 221000000
Depreciation & amortization: 158000000
Net tangible assets: -8933000000
Owner earnings: 512000000
Return on net tangible assets (%): -5.731557147654763
Capex to operating income (%): 11.367380560131796
Buffett classification: The Great
Stock price: 87.92941176470588
P/E ratio: 38.701221661213516
Shares outstanding: 558977372
Book value: 12030000000
P/B ratio: 4.085665129654296
Market cap (USD): 49150551509.74117
Debt to equity: 0.7940149625935162
Current ratio: 0.9859831278390655
Quick ratio: 0.9859831278390655
Effective tax rate (%): 20.03780718336484
Interest coverage ratio: 7.226190476190476
COGS to revenue (%): 55.566905005107245
SG&A to revenue (%): 5.362614913176711
Free cash flow (dilution-adjusted): 111000000
Buyback yield (%): 0.23397499411010292
Retained earnings: 9223000000
Receivables turnover: 2.263583815028902
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6449954246372394
FCF margin (%): 5.6690500510725235
Revenue growth (%): -6.806282722513089
Rule of 40 score: -1.1372326714405654
Financial ratios for NAQ.DE — annual report dated 2025-12-31
Total revenue: 8262000000
Gross profit: 3489000000
Operating income: 2433000000
Net income: 1788000000
Capital expenditures: 266000000
Operating cash flow: 2255000000
Depreciation & amortization: 632000000
Net tangible assets: -8655000000
Owner earnings: 2154000000
Return on net tangible assets (%): -24.88734835355286
Capex to operating income (%): 10.933004521167284
Buffett classification: The Great
Stock price: 97.87058823529412
P/E ratio: 30.59700459052507
Shares outstanding: 558977372
Book value: 12232000000
P/B ratio: 4.472485628503828
Market cap (USD): 54707444207.858826
Debt to equity: 0.7738718116415958
Current ratio: 1.0052757191307624
Quick ratio: 1.0052757191307624
Effective tax rate (%): 16.68997668997669
Interest coverage ratio: 6.872881355932203
COGS to revenue (%): 57.770515613652876
SG&A to revenue (%): 5.13192931493585
Free cash flow (dilution-adjusted): 1824000000
Buyback yield (%): 1.1259893583394827
Retained earnings: 9588000000
Receivables turnover: 8.761399787910923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.53611640394942
FCF margin (%): 22.076978939724036
Revenue growth (%): 11.64864864864865
Rule of 40 score: 33.72562758837269
Financial ratios for NAQ.DE — quarterly report dated 2025-12-31
Total revenue: 2124000000
Gross profit: 942000000
Operating income: 651000000
Net income: 518000000
Capital expenditures: 89000000
Operating cash flow: 625000000
Depreciation & amortization: 161000000
Net tangible assets: -8655000000
Owner earnings: 590000000
Return on net tangible assets (%): -6.81686886192952
Capex to operating income (%): 13.671274961597543
Buffett classification: The Great
Stock price: 97.87058823529412
P/E ratio: 30.59700459052507
Shares outstanding: 558977372
Book value: 12232000000
P/B ratio: 4.472485628503828
Market cap (USD): 54707444207.858826
Debt to equity: 0.7738718116415958
Current ratio: 1.0052757191307624
Quick ratio: 1.0052757191307624
Effective tax rate (%): 10.689655172413794
Interest coverage ratio: 7.658823529411765
COGS to revenue (%): 55.6497175141243
SG&A to revenue (%): 6.120527306967985
Free cash flow (dilution-adjusted): 493000000
Buyback yield (%): 0.5227807735147597
Retained earnings: 9588000000
Receivables turnover: 2.2523860021208906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8191581500086613
FCF margin (%): 23.210922787193976
Revenue growth (%): 8.478038815117467
Rule of 40 score: 31.688961602311444
Financial ratios for NTNX — annual report dated 2021-07-31
Capital expenditures: 0
Depreciation & amortization: 2604000
Buffett classification: The Gruesome
Stock price: 36.02
Shares outstanding: 270320509
Market cap (USD): 9736944734.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTNX — annual report dated 2022-07-31
Total revenue: 1580796000
Gross profit: 1259640000
Operating income: -458852000
Net income: -798946000
Capital expenditures: 49058000
Operating cash flow: 67543000
Depreciation & amortization: 87952000
Net tangible assets: -1001593000
Owner earnings: -760052000
Buffett classification: The Gruesome
Stock price: 15.13
Shares outstanding: 270320509
Book value: -800504000
Market cap (USD): 4089949301.17
Debt to equity: -1.7879286049788634
Current ratio: 1.4286042944785275
Quick ratio: 1.4286042944785275
Interest coverage ratio: -7.5551091645536275
COGS to revenue (%): 20.31609391724169
R&D to revenue (%): 36.24749809589599
SG&A to revenue (%): 72.46305026075471
Free cash flow (dilution-adjusted): -324761000
Buyback yield (%): 1.4320470912254353
Retained earnings: -4378362000
Receivables turnover: 11.969107993306732
Capitalized R&D asset: 572999000
ROCI (R&D-adjusted, %): -4.321965206528593
FCF margin (%): -20.54414358335927
Rule of 40 score: -20.54414358335927
Financial ratios for NTNX — annual report dated 2023-07-31
Total revenue: 1862895000
Gross profit: 1530708000
Operating income: -207150000
Net income: -254560000
Capital expenditures: 65404000
Operating cash flow: 272403000
Depreciation & amortization: 76388000
Net tangible assets: -897250000
Owner earnings: -243576000
Buffett classification: The Gruesome
Stock price: 30.2
Shares outstanding: 270320509
Book value: -707419000
Market cap (USD): 8163679371.8
Debt to equity: -1.8612335829261017
Current ratio: 1.6386945607283814
Quick ratio: 1.6386945607283814
Interest coverage ratio: -3.231013990922278
COGS to revenue (%): 17.831761854532864
R&D to revenue (%): 31.185922985460802
SG&A to revenue (%): 62.1021045201152
Free cash flow (dilution-adjusted): -104746000
Buyback yield (%): 0
Retained earnings: -4632922000
Receivables turnover: 11.414448086762048
Capitalized R&D asset: 964870330
ROCI (R&D-adjusted, %): -0.46026394172300805
Rosenberg metric: 0.47306888842737943
FCF margin (%): -5.622753832073197
Revenue growth (%): 17.84537663303804
Rule of 40 score: 12.222622800964842
Financial ratios for NTNX — annual report dated 2024-07-31
Total revenue: 2148816000
Gross profit: 1824704000
Operating income: 7563000
Net income: -124775000
Capital expenditures: 75252000
Operating cash flow: 672931000
Depreciation & amortization: 73199000
Net tangible assets: -918536000
Owner earnings: -126828000
Capex to operating income (%): 995.0019833399444
Buffett classification: The Gruesome
Stock price: 50.51
Shares outstanding: 270320509
Book value: -728148000
Market cap (USD): 13653888909.59
Debt to equity: -0.9401866104143664
Current ratio: 1.1904244897499963
Quick ratio: 1.1904244897499963
Interest coverage ratio: 0.04465108041091038
COGS to revenue (%): 15.083283073096998
R&D to revenue (%): 29.736934200043187
SG&A to revenue (%): 54.827821460748616
Free cash flow (dilution-adjusted): 263846000
Buyback yield (%): 0.9604516403227267
Retained earnings: -4847199000
Receivables turnover: 9.035738164019628
Capitalized R&D asset: 1217325540
ROCI (R&D-adjusted, %): 2.3101835067633
Rosenberg metric: 0.5060511807160893
FCF margin (%): 12.278668811103417
Revenue growth (%): 15.348208031048449
Rule of 40 score: 27.626876842151866
Financial ratios for NTNX — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 62.1
Shares outstanding: 270320509
Market cap (USD): 16786903608.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTNX — quarterly report dated 2025-01-31
Total revenue: 654721000
Gross profit: 569433000
Operating income: 65438000
Net income: 56427000
Capital expenditures: 34607000
Operating cash flow: 221670000
Depreciation & amortization: 18247000
Net tangible assets: -996352000
Owner earnings: 40067000
Return on net tangible assets (%): -4.021369957605344
Capex to operating income (%): 52.88517375225405
Buffett classification: The Good
Stock price: 68.76
P/E ratio: 82.35081697963741
Shares outstanding: 270320509
Book value: -807674000
Market cap (USD): 18587238198.84
Debt to equity: -1.8039889856551035
Current ratio: 1.7725224165385252
Quick ratio: 1.7725224165385252
Effective tax rate (%): 13.299940076517677
Interest coverage ratio: 39.090800477897254
COGS to revenue (%): 13.026617444682545
R&D to revenue (%): 27.917998658970767
SG&A to revenue (%): 49.04715138203907
Free cash flow (dilution-adjusted): 93635000
Buyback yield (%): 1.0760070854016477
Retained earnings: -4928614000
Receivables turnover: 1.9515772781333183
Capitalized R&D asset: 182785000
ROCI (R&D-adjusted, %): 10.10098940022072
FCF margin (%): 14.301511636254222
Rule of 40 score: 14.301511636254222
Financial ratios for NTNX — quarterly report dated 2025-04-30
Total revenue: 638983000
Gross profit: 555992000
Operating income: 48645000
Net income: 63363000
Capital expenditures: 15095000
Operating cash flow: 218506000
Depreciation & amortization: 18024000
Net tangible assets: -899478000
Owner earnings: 66292000
Return on net tangible assets (%): -7.3700524081745185
Capex to operating income (%): 31.03093843149347
Buffett classification: The Good
Stock price: 68.7
P/E ratio: 73.27233151957768
Shares outstanding: 270320509
Book value: -711434000
Market cap (USD): 18571018968.3
Debt to equity: -2.0914139610982887
Current ratio: 1.8813418074136499
Quick ratio: 1.8813418074136499
Effective tax rate (%): 1.9133423118004922
Interest coverage ratio: 16.489830508474576
COGS to revenue (%): 12.9879824658872
R&D to revenue (%): 29.1733895893944
SG&A to revenue (%): 50.21182097176295
Free cash flow (dilution-adjusted): 119169000
Buyback yield (%): 0.20332217669075206
Retained earnings: -4894397000
Receivables turnover: 2.2823592864847875
Capitalized R&D asset: 308878950
ROCI (R&D-adjusted, %): 5.27280735064901
Rosenberg metric: -0.0735344804004705
FCF margin (%): 18.649791934996706
Revenue growth (%): -2.4037719883736735
Rule of 40 score: 16.246019946623033
Financial ratios for NTNX — quarterly report dated 2025-07-31
Total revenue: 653267000
Gross profit: 569434000
Operating income: 31208000
Net income: 38650000
Capital expenditures: 11750000
Operating cash flow: 219529000
Depreciation & amortization: 18250000
Net tangible assets: -882370000
Owner earnings: 45150000
Return on net tangible assets (%): -5.116901073245917
Capex to operating income (%): 37.65060240963856
Buffett classification: The Good
Stock price: 75.17
P/E ratio: 128.25039549059582
Shares outstanding: 270320509
Book value: -694520000
Market cap (USD): 20319992661.53
Debt to equity: -2.1350083510914013
Current ratio: 1.8316879383052915
Quick ratio: 1.8316879383052915
Effective tax rate (%): 14.383182331701484
Interest coverage ratio: 10.375
COGS to revenue (%): 12.83288456327964
R&D to revenue (%): 29.645765054717288
SG&A to revenue (%): 52.78469599719563
Free cash flow (dilution-adjusted): 122608000
Buyback yield (%): 0.24626485271689144
Retained earnings: -4895693000
Receivables turnover: 1.8756786865853343
Capitalized R&D asset: 378881760
ROCI (R&D-adjusted, %): 1.656752981068732
Rosenberg metric: 0.07210870486500405
FCF margin (%): 18.768436183061443
Revenue growth (%): 2.235427233588374
Rule of 40 score: 21.003863416649818
Financial ratios for NTNX — annual report dated 2025-07-31
Total revenue: 2537927000
Gross profit: 2203145000
Operating income: 172541000
Net income: 188366000
Capital expenditures: 71283000
Operating cash flow: 821456000
Depreciation & amortization: 72701000
Net tangible assets: -882370000
Owner earnings: 189784000
Return on net tangible assets (%): -21.508437503541597
Capex to operating income (%): 41.313658782550235
Buffett classification: The Good
Stock price: 75.17
P/E ratio: 107.87505527287303
Shares outstanding: 270320509
Book value: -694520000
Market cap (USD): 20319992661.53
Debt to equity: -2.1350083510914013
Current ratio: 1.8316879383052915
Quick ratio: 1.8316879383052915
Effective tax rate (%): 11.0003401874811
Interest coverage ratio: 20.59453330150394
COGS to revenue (%): 13.191159556598752
R&D to revenue (%): 29.03247414129721
SG&A to revenue (%): 50.97786500557344
Free cash flow (dilution-adjusted): 398583000
Buyback yield (%): 1.5152564527393713
Retained earnings: -4895693000
Receivables turnover: 7.286967781947439
Capitalized R&D asset: 1356664770
ROCI (R&D-adjusted, %): 7.969002177157936
Rosenberg metric: 0.592246851290783
FCF margin (%): 15.705061650709418
Revenue growth (%): 18.108158167102257
Rule of 40 score: 33.81321981781167
Financial ratios for NTNX — quarterly report dated 2025-10-31
Total revenue: 670576000
Gross profit: 583106000
Operating income: 49335000
Net income: 62096000
Capital expenditures: 22319000
Operating cash flow: 196825000
Depreciation & amortization: 18374000
Net tangible assets: -856284000
Owner earnings: 58151000
Return on net tangible assets (%): -6.791088003512853
Capex to operating income (%): 45.239687848383504
Buffett classification: The Good
Stock price: 71.24
P/E ratio: 87.32194771447745
Shares outstanding: 270320509
Book value: -668628000
Market cap (USD): 19257633061.16
Debt to equity: -2.2143090029134287
Current ratio: 1.8851970199302346
Quick ratio: 1.8851970199302346
Effective tax rate (%): 5.303931436239973
Interest coverage ratio: 16.483461409956565
COGS to revenue (%): 13.04400992579514
R&D to revenue (%): 27.95835222256687
SG&A to revenue (%): 51.640529932475964
Free cash flow (dilution-adjusted): 96746000
Buyback yield (%): 0.2608056755494886
Retained earnings: -4873137000
Receivables turnover: 1.9333927268848081
Capitalized R&D asset: 378754510
ROCI (R&D-adjusted, %): 2.068249623495413
Rosenberg metric: 0.07059576797166256
FCF margin (%): 14.427298322636062
Revenue growth (%): 2.6496057507879627
Rule of 40 score: 17.076904073424025
Financial ratios for NTNX — quarterly report dated 2026-01-31
Total revenue: 722825000
Gross profit: 631552000
Operating income: 84137000
Net income: 103022000
Capital expenditures: 5928000
Operating cash flow: 197346000
Depreciation & amortization: 18048000
Net tangible assets: -1018749000
Owner earnings: 115142000
Return on net tangible assets (%): -11.30229330286459
Capex to operating income (%): 7.045651734670834
Buffett classification: The Great
Stock price: 39.33
P/E ratio: 39.79959502629796
Shares outstanding: 270320509
Book value: -831287000
Market cap (USD): 10631705618.97
Debt to equity: -1.8561459519997305
Current ratio: 1.6545050427254668
Quick ratio: 1.6545050427254668
Effective tax rate (%): -5.658171375826881
Interest coverage ratio: 28.092487479131886
COGS to revenue (%): 12.627261093625705
R&D to revenue (%): 27.981738318403487
SG&A to revenue (%): 47.73880261474077
Free cash flow (dilution-adjusted): 88854000
Buyback yield (%): 3.1309463592187834
Retained earnings: -4986383000
Receivables turnover: 2.678856003498551
Capitalized R&D asset: 391781720
ROCI (R&D-adjusted, %): 4.220413075724587
Rosenberg metric: 0.2584034734001131
FCF margin (%): 12.292601943762321
Revenue growth (%): 7.791659707475364
Rule of 40 score: 20.084261651237686
Financial ratios for OMCL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 180.44
Shares outstanding: 45478909
Market cap (USD): 8206214339.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMCL — annual report dated 2022-12-31
Total revenue: 1295947000
Gross profit: 588987000
Operating income: -2323000
Net income: 5648000
Capital expenditures: 47536000
Operating cash flow: 77781000
Depreciation & amortization: 99169000
Net tangible assets: 72197000
Owner earnings: 57281000
Return on net tangible assets (%): 79.33986176710943
Buffett classification: The Gruesome
Stock price: 50.42
P/E ratio: 405.992668516289
Shares outstanding: 45478909
Book value: 1130137000
P/B ratio: 2.0289987778295906
Market cap (USD): 2293046591.78
Debt to equity: 0.5457187933852268
Current ratio: 2.0581636892397177
Quick ratio: 1.7137819001694496
COGS to revenue (%): 54.55161360765525
R&D to revenue (%): 8.099791118000969
SG&A to revenue (%): 37.52784643199143
Free cash flow (dilution-adjusted): -51206000
Buyback yield (%): 2.2768835219990655
Retained earnings: 390728000
Inventory turnover: 4.7913574473564715
Receivables turnover: 4.327482978204756
Capitalized R&D asset: 104969000
ROCI (R&D-adjusted, %): 3.58485743952985
FCF margin (%): -3.9512418331922525
Rule of 40 score: -3.9512418331922525
Financial ratios for OMCL — annual report dated 2023-12-31
Total revenue: 1147112000
Gross profit: 496840000
Operating income: -34868000
Net income: -20371000
Capital expenditures: 41474000
Operating cash flow: 181094000
Depreciation & amortization: 95558000
Net tangible assets: 175312000
Owner earnings: 33713000
Buffett classification: The Gruesome
Stock price: 37.63
Shares outstanding: 45478909
Book value: 1188954000
P/B ratio: 1.4393923950548129
Market cap (USD): 1711371345.67
Debt to equity: 0.5164960124613737
Current ratio: 2.52199884717449
Quick ratio: 2.222647583416714
COGS to revenue (%): 56.68775150116117
R&D to revenue (%): 8.466043420346052
SG&A to revenue (%): 37.88583852317821
Free cash flow (dilution-adjusted): 70778000
Buyback yield (%): 0
Retained earnings: 370357000
Inventory turnover: 5.906248013151799
Receivables turnover: 4.5515802003769466
Capitalized R&D asset: 167444230
ROCI (R&D-adjusted, %): -0.2523689633454581
Rosenberg metric: -0.8778496508492983
FCF margin (%): 6.170103703910342
Revenue growth (%): -11.484651764308262
Rule of 40 score: -5.314548060397921
Financial ratios for OMCL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 43.6
Shares outstanding: 45478909
Market cap (USD): 1982880432.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMCL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.52
Shares outstanding: 45478909
Market cap (USD): 2024721028.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMCL — annual report dated 2024-12-31
Total revenue: 1112238000
Gross profit: 471003000
Operating income: 337000
Net income: 12531000
Capital expenditures: 36463000
Operating cash flow: 187722000
Depreciation & amortization: 89755000
Net tangible assets: 261884000
Owner earnings: 65823000
Return on net tangible assets (%): 25.134410655099202
Capex to operating income (%): 10819.881305637982
Buffett classification: The Gruesome
Stock price: 44.52
P/E ratio: 161.57697140531482
Shares outstanding: 45478909
Book value: 1243313000
P/B ratio: 1.6284885854808886
Market cap (USD): 2024721028.68
Debt to equity: 0.3076827797988117
Current ratio: 1.369016482059099
Quick ratio: 1.2201793586467857
Effective tax rate (%): 51.037393037158594
COGS to revenue (%): 57.652678653309806
R&D to revenue (%): 8.128835734797768
SG&A to revenue (%): 34.18818634141254
Free cash flow (dilution-adjusted): 95613000
Buyback yield (%): 0
Retained earnings: 382888000
Inventory turnover: 7.232599059317159
Receivables turnover: 4.337935553319449
Capitalized R&D asset: 190118820
ROCI (R&D-adjusted, %): -0.39347460884778357
Rosenberg metric: -0.266045410080832
FCF margin (%): 8.596451478910089
Revenue growth (%): -3.0401564973603272
Rule of 40 score: 5.556294981549762
Financial ratios for OMCL — quarterly report dated 2025-03-31
Total revenue: 269668000
Gross profit: 110936000
Operating income: -11619000
Net income: -7023000
Capital expenditures: 11172000
Operating cash flow: 25924000
Depreciation & amortization: 21841000
Net tangible assets: 281057000
Owner earnings: 3646000
Buffett classification: The Gruesome
Stock price: 34.96
Shares outstanding: 45478909
Book value: 1257100000
P/B ratio: 1.2647702319942726
Market cap (USD): 1589942658.64
Debt to equity: 0.30691830403309206
Current ratio: 1.3820950995173917
Quick ratio: 1.2320750182706426
COGS to revenue (%): 58.862008098847475
R&D to revenue (%): 7.611581648545619
SG&A to revenue (%): 37.83504160671641
Free cash flow (dilution-adjusted): -601000
Buyback yield (%): 0
Retained earnings: 375865000
Inventory turnover: 1.7415900463013758
Receivables turnover: 1.0718251807453985
Capitalized R&D asset: 20526000
ROCI (R&D-adjusted, %): 0.13199408871025475
FCF margin (%): -0.22286663601168843
Rule of 40 score: -0.22286663601168843
Financial ratios for OMCL — quarterly report dated 2025-06-30
Total revenue: 290562000
Gross profit: 127678000
Operating income: 8120000
Net income: 5639000
Capital expenditures: 11781000
Operating cash flow: 42755000
Depreciation & amortization: 21646000
Net tangible assets: 291553000
Owner earnings: 15504000
Return on net tangible assets (%): 5.317729538025676
Capex to operating income (%): 145.08620689655172
Buffett classification: The Gruesome
Stock price: 29.4
P/E ratio: 59.278237480049654
Shares outstanding: 45478909
Book value: 1263619000
P/B ratio: 1.058135343485655
Market cap (USD): 1337079924.6
Debt to equity: 0.3042135327183273
Current ratio: 1.421243892919151
Quick ratio: 1.2432737991090055
Effective tax rate (%): 46.05376446953028
COGS to revenue (%): 56.05825951087892
R&D to revenue (%): 7.424577198670164
SG&A to revenue (%): 33.722579002071846
Free cash flow (dilution-adjusted): 16302000
Buyback yield (%): 0
Retained earnings: 381504000
Inventory turnover: 1.5397791726537093
Receivables turnover: 1.2487515149431412
Capitalized R&D asset: 35325420
ROCI (R&D-adjusted, %): 0.9871223895986497
Rosenberg metric: 0.8156484458735263
FCF margin (%): 5.6105065356103
Revenue growth (%): 7.748045745138467
Rule of 40 score: 13.358552280748768
Financial ratios for OMCL — quarterly report dated 2025-09-30
Total revenue: 310631000
Gross profit: 134503000
Operating income: 8244000
Net income: 5462000
Capital expenditures: 9753000
Operating cash flow: 28267000
Depreciation & amortization: 21365000
Net tangible assets: 255266000
Owner earnings: 17074000
Return on net tangible assets (%): 6.688709032930356
Capex to operating income (%): 118.3042212518195
Buffett classification: The Gruesome
Stock price: 30.45
P/E ratio: 339.5862626410005
Shares outstanding: 45478909
Book value: 1220902000
P/B ratio: 1.1342702191084952
Market cap (USD): 1384832779.05
Debt to equity: 0.16936985933350915
Current ratio: 1.4446722209081273
Quick ratio: 1.209385704398714
Effective tax rate (%): 43.708131505719884
COGS to revenue (%): 56.700071789357786
R&D to revenue (%): 7.732969343046895
SG&A to revenue (%): 32.91300610692429
Free cash flow (dilution-adjusted): 2776000
Buyback yield (%): 4.4733198792778825
Retained earnings: 386966000
Inventory turnover: 1.6394828212121495
Receivables turnover: 1.2641665310109067
Capitalized R&D asset: 45248490
ROCI (R&D-adjusted, %): 0.6651455638703703
Rosenberg metric: 0.31636768182450287
FCF margin (%): 0.8936648306189658
Revenue growth (%): 6.906959616192069
Rule of 40 score: 7.800624446811035
Financial ratios for OMCL — quarterly report dated 2025-12-31
Total revenue: 313984000
Gross profit: 130325000
Operating income: 415000
Net income: -2026000
Capital expenditures: 7709000
Operating cash flow: 30354000
Depreciation & amortization: 21782000
Net tangible assets: 269566000
Owner earnings: 12047000
Capex to operating income (%): 1857.5903614457832
Buffett classification: The Gruesome
Stock price: 45.3
P/E ratio: 1003.9934589181286
Shares outstanding: 45478909
Book value: 1231814000
P/B ratio: 1.6724883608239554
Market cap (USD): 2060194577.6999998
Debt to equity: 0.1658894930565816
Current ratio: 1.4268908056708958
Quick ratio: 1.2151763814783187
Effective tax rate (%): 389.84263233190273
COGS to revenue (%): 58.49310792906645
R&D to revenue (%): 7.182531593966572
SG&A to revenue (%): 34.19218813697513
Free cash flow (dilution-adjusted): 6388000
Buyback yield (%): 0
Retained earnings: 384940000
Inventory turnover: 1.8201179327089836
Receivables turnover: 1.4478783351317452
Capitalized R&D asset: 45765160
ROCI (R&D-adjusted, %): 0.016300962032257036
Rosenberg metric: -0.17393114358269848
FCF margin (%): 2.0344985731757035
Revenue growth (%): 1.0794157698362365
Rule of 40 score: 3.11391434301194
Financial ratios for OMCL — annual report dated 2025-12-31
Total revenue: 1184845000
Gross profit: 503442000
Operating income: 5160000
Net income: 2052000
Capital expenditures: 40415000
Operating cash flow: 127300000
Depreciation & amortization: 86634000
Net tangible assets: 269566000
Owner earnings: 48271000
Return on net tangible assets (%): 17.906931883100984
Capex to operating income (%): 783.2364341085271
Buffett classification: The Gruesome
Stock price: 45.3
P/E ratio: 1003.9934589181286
Shares outstanding: 45478909
Book value: 1231814000
P/B ratio: 1.6724883608239554
Market cap (USD): 2060194577.6999998
Debt to equity: 0.1658894930565816
Current ratio: 1.4268908056708958
Quick ratio: 1.2151763814783187
Effective tax rate (%): 81.88079470198676
COGS to revenue (%): 57.50988525925332
R&D to revenue (%): 7.483848098274458
SG&A to revenue (%): 34.570766640362244
Free cash flow (dilution-adjusted): 24865000
Buyback yield (%): 3.7666345130678196
Retained earnings: 384940000
Inventory turnover: 6.752916109211634
Receivables turnover: 5.4636905255973955
Capitalized R&D asset: 181295990
ROCI (R&D-adjusted, %): 0.10513631759188234
Rosenberg metric: 0.3587908684687873
FCF margin (%): 2.098586734973773
Revenue growth (%): 6.528009292975065
Rule of 40 score: 8.626596027948837
Financial ratios for PCYO — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.95
Shares outstanding: 24097370
Market cap (USD): 360255681.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCYO — annual report dated 2022-08-31
Total revenue: 23003000
Gross profit: 16374000
Operating income: 10096000
Net income: 9619000
Capital expenditures: 5819000
Operating cash flow: 17454000
Depreciation & amortization: 2125000
Net tangible assets: 112545000
Owner earnings: 5925000
Return on net tangible assets (%): 5.264560842329734
Capex to operating income (%): 57.63668779714739
Buffett classification: The Good
Stock price: 10.32
P/E ratio: 25.85350435596216
Shares outstanding: 24097370
Book value: 112996000
P/B ratio: 2.2008288647385745
Market cap (USD): 248684858.4
Debt to equity: 0.036266770505150626
Current ratio: 3.4912685946595214
Quick ratio: 3.4912685946595214
Effective tax rate (%): 24.2896497441952
Interest coverage ratio: 112.17777777777778
COGS to revenue (%): 28.8179802634439
SG&A to revenue (%): 25.618397600313003
Free cash flow (dilution-adjusted): 11032000
Buyback yield (%): 0
Retained earnings: -61234000
Receivables turnover: 9.48577319587629
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.52659493606743
FCF margin (%): 47.958961874538105
Rule of 40 score: 47.958961874538105
Financial ratios for PCYO — annual report dated 2023-08-31
Total revenue: 14586000
Gross profit: 8040000
Operating income: 2072000
Net income: 4699000
Capital expenditures: 7811000
Operating cash flow: -2339000
Depreciation & amortization: 2156000
Net tangible assets: 117783000
Owner earnings: -956000
Return on net tangible assets (%): -0.8116621244152381
Capex to operating income (%): 376.97876447876445
Buffett classification: The Gruesome
Stock price: 10.99
P/E ratio: 56.358820238348585
Shares outstanding: 24097370
Book value: 118234000
P/B ratio: 2.2398810519816634
Market cap (USD): 264830096.3
Debt to equity: 0.061538982018708666
Current ratio: 4.571274796247885
Quick ratio: 4.30585883438413
Effective tax rate (%): 24.45337620578778
Interest coverage ratio: 10.058252427184467
COGS to revenue (%): 44.878650761003705
SG&A to revenue (%): 37.501713972302205
Free cash flow (dilution-adjusted): -10689000
Buyback yield (%): 0
Retained earnings: -56535000
Inventory turnover: 3.7925840092699885
Receivables turnover: 8.877662811929397
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.635191337905345
FCF margin (%): -73.282599753188
Revenue growth (%): -36.590879450506456
Rule of 40 score: -109.87347920369444
Financial ratios for PCYO — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.65
Shares outstanding: 24097370
Market cap (USD): 256636990.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCYO — annual report dated 2024-08-31
Total revenue: 28747000
Gross profit: 19759000
Operating income: 12242000
Net income: 11613000
Capital expenditures: 2382000
Operating cash flow: 2312000
Depreciation & amortization: 2100000
Net tangible assets: 129702000
Owner earnings: 11331000
Return on net tangible assets (%): 8.736179858444743
Capex to operating income (%): 19.45760496650874
Buffett classification: The Great
Stock price: 10.65
P/E ratio: 22.09911224489796
Shares outstanding: 24097370
Book value: 129702000
P/B ratio: 1.9786664083822918
Market cap (USD): 256636990.5
Debt to equity: 0.054316818553299104
Current ratio: 4.049844903198203
Quick ratio: 3.659749705850893
Effective tax rate (%): 25.710081883316278
Interest coverage ratio: 27.886104783599087
COGS to revenue (%): 31.265871221344838
SG&A to revenue (%): 24.07555571016106
Free cash flow (dilution-adjusted): -506000
Buyback yield (%): 0.22638981187709958
Retained earnings: -45503000
Inventory turnover: 2.4644913627639156
Receivables turnover: 2.4841859661251298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.870693090830043
FCF margin (%): -1.7601836713396182
Revenue growth (%): 97.08624708624708
Rule of 40 score: 95.32606341490747
Financial ratios for PCYO — quarterly report dated 2024-11-30
Capital expenditures: 6108000
Buffett classification: The Gruesome
Stock price: 14.54
Shares outstanding: 24097370
Market cap (USD): 350375759.79999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCYO — quarterly report dated 2025-02-28
Total revenue: 3995000
Gross profit: 1527000
Operating income: -1327000
Net income: 809000
Capital expenditures: 43000
Operating cash flow: -1372000
Depreciation & amortization: 617000
Net tangible assets: 134412000
Owner earnings: 1383000
Return on net tangible assets (%): 1.0289259887510043
Buffett classification: The Gruesome
Stock price: 11.63
P/E ratio: 86.60457759579728
Shares outstanding: 24097370
Book value: 134412000
P/B ratio: 2.085025244025831
Market cap (USD): 280252413.1
Debt to equity: 0.05212332232241169
Current ratio: 3.759192200557103
Quick ratio: 3.1168523676880224
Effective tax rate (%): 24.814126394052042
Interest coverage ratio: -12.174311926605505
COGS to revenue (%): 61.77722152690863
SG&A to revenue (%): 67.70963704630788
Free cash flow (dilution-adjusted): -1538000
Buyback yield (%): 0.0688664899849171
Retained earnings: -41058000
Inventory turnover: 0.5351257588898526
Receivables turnover: 0.8380532829872037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9313849350065975
FCF margin (%): -38.49812265331665
Rule of 40 score: -38.49812265331665
Financial ratios for PCYO — quarterly report dated 2025-05-31
Total revenue: 5140000
Gross profit: 3257000
Operating income: 1334000
Net income: 2256000
Capital expenditures: 1095000
Operating cash flow: -428000
Depreciation & amortization: 534000
Net tangible assets: 136675000
Owner earnings: 1695000
Return on net tangible assets (%): 1.2401682824218034
Capex to operating income (%): 82.0839580209895
Buffett classification: The Gruesome
Stock price: 10.62
P/E ratio: 83.49561807504078
Shares outstanding: 24097370
Book value: 136675000
P/B ratio: 1.8724277987927564
Market cap (USD): 255914069.39999998
Debt to equity: 0.050287177611121274
Current ratio: 3.5236963511813224
Quick ratio: 2.3957779952467497
Effective tax rate (%): 24.624122953558302
Interest coverage ratio: 13.207920792079207
COGS to revenue (%): 36.63424124513618
SG&A to revenue (%): 34.98054474708171
Free cash flow (dilution-adjusted): -1552000
Buyback yield (%): 0.00859663560177829
Retained earnings: -38824000
Inventory turnover: 0.23339117501239465
Receivables turnover: 2.6171079429735236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9226342799441163
FCF margin (%): -30.19455252918288
Revenue growth (%): 28.660826032540676
Rule of 40 score: -1.5337264966422026
Financial ratios for PCYO — annual report dated 2025-08-31
Total revenue: 26087000
Gross profit: 16030000
Operating income: 7670000
Net income: 13110000
Capital expenditures: 9294000
Operating cash flow: 13164000
Depreciation & amortization: 2297000
Net tangible assets: 142738000
Owner earnings: 6113000
Return on net tangible assets (%): 4.28267174823803
Capex to operating income (%): 121.17340286831812
Buffett classification: The Gruesome
Stock price: 10.1
P/E ratio: 18.564716781083142
Shares outstanding: 24097370
Book value: 142738000
P/B ratio: 1.7051061175019966
Market cap (USD): 243383437
Debt to equity: 0.04766775490759293
Current ratio: 2.7242447714949654
Quick ratio: 2.0883897065151906
Effective tax rate (%): 24.9570692615913
Interest coverage ratio: 18.004694835680752
COGS to revenue (%): 38.551769080384865
SG&A to revenue (%): 29.78495035841607
Free cash flow (dilution-adjusted): 3368000
Buyback yield (%): 0.16311709822718956
Retained earnings: -32790000
Inventory turnover: 1.361261505143476
Receivables turnover: 19.614285714285714
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.090933227133944
FCF margin (%): 12.910645148924752
Revenue growth (%): -9.253139458030404
Rule of 40 score: 3.6575056908943484
Financial ratios for PCYO — quarterly report dated 2025-08-31
Total revenue: 11200000
Gross profit: 7580000
Operating income: 5944000
Net income: 6108000
Capital expenditures: 2134000
Operating cash flow: 9365000
Depreciation & amortization: 620000
Net tangible assets: 142738000
Owner earnings: 4594000
Return on net tangible assets (%): 3.2184842158360074
Capex to operating income (%): 35.901749663526246
Buffett classification: The Good
Stock price: 10.1
P/E ratio: 26.532588793197426
Shares outstanding: 24097370
Book value: 142738000
P/B ratio: 1.7051061175019966
Market cap (USD): 243383437
Debt to equity: 0.04766775490759293
Current ratio: 2.7242447714949654
Quick ratio: 2.0883897065151906
Effective tax rate (%): 25.44855364335408
Interest coverage ratio: 55.55140186915888
COGS to revenue (%): 32.32142857142858
SG&A to revenue (%): 13.169642857142858
Free cash flow (dilution-adjusted): 7023000
Buyback yield (%): 0.03040469841010586
Retained earnings: -32790000
Inventory turnover: 0.4899837574445046
Receivables turnover: 8.421052631578947
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9453073144829416
FCF margin (%): 62.705357142857146
Revenue growth (%): 117.89883268482491
Rule of 40 score: 180.60418982768206
Financial ratios for PCYO — quarterly report dated 2025-11-30
Total revenue: 9135000
Gross profit: 6251000
Operating income: 4383000
Net income: 4565000
Capital expenditures: 1727000
Operating cash flow: -979000
Depreciation & amortization: 566000
Net tangible assets: 147486000
Owner earnings: 3404000
Return on net tangible assets (%): 2.308015676064169
Capex to operating income (%): 39.402235911476154
Buffett classification: The Good
Stock price: 11.38
P/E ratio: 19.961280433833167
Shares outstanding: 24097370
Book value: 147486000
P/B ratio: 1.8593498406628428
Market cap (USD): 274228070.6
Debt to equity: 0.05426955778853586
Current ratio: 2.286124651810585
Quick ratio: 1.7453864902506964
Effective tax rate (%): 24.29519071310116
Interest coverage ratio: 46.62765957446808
COGS to revenue (%): 31.570881226053636
SG&A to revenue (%): 18.708264915161465
Free cash flow (dilution-adjusted): -2889000
Buyback yield (%): 0
Retained earnings: -28225000
Inventory turnover: 0.4642627173213136
Receivables turnover: 3.6510791366906474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7991901954898744
FCF margin (%): -31.6256157635468
Revenue growth (%): -18.4375
Rule of 40 score: -50.063115763546804
Financial ratios for PDM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.45
Shares outstanding: 125019003
Market cap (USD): 1806524593.35
Buyback yield (%): 1.081468808778894
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PDM — annual report dated 2022-12-31
Total revenue: 563766000
Gross profit: 337708000
Operating income: 84028000
Net income: 146830000
Capital expenditures: 121359000
Operating cash flow: 215215000
Depreciation & amortization: 224553000
Net tangible assets: 1764730000
Owner earnings: 250024000
Return on net tangible assets (%): 14.167833039615124
Capex to operating income (%): 144.4268577140953
Buffett classification: The Gruesome
Stock price: 7.69
P/E ratio: 6.547681897909146
Shares outstanding: 125019003
Book value: 1849255000
P/B ratio: 0.5198829437097642
Market cap (USD): 961396133.07
Debt to equity: 1.1034876206904942
Current ratio: 1.0037875690042937
Quick ratio: 1.0037875690042937
Interest coverage ratio: 1.2798221030827341
COGS to revenue (%): 41.722629601643234
SG&A to revenue (%): 5.166505252179095
Free cash flow (dilution-adjusted): 84888000
Buyback yield (%): 0
Retained earnings: -1855893000
Receivables turnover: 3.189064435657678
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1601666887324433
FCF margin (%): 15.057311012015623
Rule of 40 score: 15.057311012015623
Financial ratios for PDM — annual report dated 2023-12-31
Total revenue: 577756000
Gross profit: 342665000
Operating income: 77261000
Net income: -48377000
Capital expenditures: 158191000
Operating cash flow: 210131000
Depreciation & amortization: 236214000
Net tangible assets: 1667923000
Owner earnings: 29646000
Capex to operating income (%): 204.74883835311476
Buffett classification: The Gruesome
Stock price: 6.56
Shares outstanding: 125019003
Book value: 1722972000
P/B ratio: 0.4759941889247184
Market cap (USD): 820124659.68
Debt to equity: 1.2173854247196123
Current ratio: 0.8174323348782708
Quick ratio: 0.8174323348782708
Interest coverage ratio: 0.7630113176242864
COGS to revenue (%): 42.31180636808618
SG&A to revenue (%): 5.05230581768082
Free cash flow (dilution-adjusted): 43847000
Buyback yield (%): 0
Retained earnings: -1987147000
Receivables turnover: 3.0285315902312195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0491791321682213
FCF margin (%): 7.589189900234701
Revenue growth (%): 2.4815260232082106
Rule of 40 score: 10.070715923442911
Financial ratios for PDM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.8
Shares outstanding: 125019003
Market cap (USD): 1225186229.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PDM — annual report dated 2024-12-31
Total revenue: 570324000
Gross profit: 336200000
Operating income: 74238000
Net income: -79064000
Capital expenditures: 212108000
Operating cash flow: 198112000
Depreciation & amortization: 226539000
Net tangible assets: 1533113000
Owner earnings: -64633000
Return on net tangible assets (%): -4.215801444511918
Capex to operating income (%): 285.71351598911605
Buffett classification: The Gruesome
Stock price: 8.99
Shares outstanding: 125019003
Book value: 1588127000
P/B ratio: 0.7077021151142194
Market cap (USD): 1123920836.97
Debt to equity: 1.4199997859113282
Current ratio: 1.154077737161724
Quick ratio: 1.154077737161724
Interest coverage ratio: 0.6036394978208548
COGS to revenue (%): 42.034001725335074
SG&A to revenue (%): 6.2110309227737215
Free cash flow (dilution-adjusted): -23548000
Buyback yield (%): 0
Retained earnings: -2128194000
Receivables turnover: 2.8615352195356913
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9316338279201983
FCF margin (%): -4.128881127218914
Revenue growth (%): -1.286356178040557
Rule of 40 score: -5.415237305259471
Financial ratios for PDM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.99
Shares outstanding: 125019003
Market cap (USD): 1123920836.97
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PDM — quarterly report dated 2025-03-31
Total revenue: 142686000
Gross profit: 84772000
Operating income: 20895000
Net income: -10098000
Capital expenditures: 39629000
Operating cash flow: 3714000
Depreciation & amortization: 56314000
Net tangible assets: 1506717000
Owner earnings: 6587000
Capex to operating income (%): 189.65781287389328
Buffett classification: The Gruesome
Stock price: 7.37
Shares outstanding: 125019003
Book value: 1561731000
P/B ratio: 0.5899799979061695
Market cap (USD): 921390052.11
Debt to equity: 1.419547284391486
Current ratio: 0.9551341885128588
Quick ratio: 0.9551341885128588
Interest coverage ratio: 0.6596268586040345
COGS to revenue (%): 41.29417041615856
SG&A to revenue (%): 5.300449939026954
Free cash flow (dilution-adjusted): -38108000
Buyback yield (%): 0
Retained earnings: -2153834000
Receivables turnover: 0.6851537065314471
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.552927711879544
FCF margin (%): -26.70759569964818
Rule of 40 score: -26.70759569964818
Financial ratios for PDM — quarterly report dated 2025-06-30
Total revenue: 140292000
Gross profit: 84682000
Operating income: 21291000
Net income: -16806000
Capital expenditures: 41943000
Operating cash flow: 50103000
Depreciation & amortization: 55431000
Net tangible assets: 1493008000
Owner earnings: -3318000
Return on net tangible assets (%): -0.22223591568163065
Capex to operating income (%): 196.99873185853178
Buffett classification: The Gruesome
Stock price: 7.29
Shares outstanding: 125019003
Book value: 1548010000
P/B ratio: 0.5887484782850241
Market cap (USD): 911388531.87
Debt to equity: 1.4253809729911306
Current ratio: 0.9716043309267705
Quick ratio: 0.9716043309267705
Interest coverage ratio: 0.6663015584903299
COGS to revenue (%): 40.251760613577396
SG&A to revenue (%): 5.673880192740855
Free cash flow (dilution-adjusted): 5703000
Buyback yield (%): 0
Retained earnings: -2170642000
Receivables turnover: 0.6635983936502831
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5670598700804075
FCF margin (%): 4.065092806432298
Revenue growth (%): -1.6778100163996466
Rule of 40 score: 2.387282790032651
Financial ratios for PDM — quarterly report dated 2025-09-30
Total revenue: 139163000
Gross profit: 83273000
Operating income: 18351000
Net income: -13457000
Capital expenditures: 34241000
Operating cash flow: 35811000
Depreciation & amortization: 57315000
Net tangible assets: 1482047000
Owner earnings: 9617000
Capex to operating income (%): 186.58928668737397
Buffett classification: The Gruesome
Stock price: 9
Shares outstanding: 125019003
Book value: 1537047000
P/B ratio: 0.7320342364286843
Market cap (USD): 1125171027
Debt to equity: 1.4444008543655464
Current ratio: 0.9150182228463355
Quick ratio: 0.9150182228463355
Interest coverage ratio: 0.5740427927927928
COGS to revenue (%): 40.78382903501649
SG&A to revenue (%): 5.46625180543679
Free cash flow (dilution-adjusted): -1009000
Buyback yield (%): 0
Retained earnings: -2184104000
Receivables turnover: 0.6403598380268728
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4884048104320776
FCF margin (%): -0.7250490432083241
Revenue growth (%): -0.8047500926638725
Rule of 40 score: -1.5297991358721967
Financial ratios for PDM — annual report dated 2025-12-31
Total revenue: 564994000
Gross profit: 337120000
Operating income: 79445000
Net income: -83601000
Capital expenditures: 157241000
Operating cash flow: 140565000
Depreciation & amortization: 227088000
Net tangible assets: 1441710000
Owner earnings: -13754000
Return on net tangible assets (%): -0.9540060067558663
Capex to operating income (%): 197.92435017936938
Buffett classification: The Gruesome
Stock price: 8.34
Shares outstanding: 125019003
Book value: 1496703000
P/B ratio: 0.696636864508189
Market cap (USD): 1042658485.02
Debt to equity: 1.502994248023823
Current ratio: 0.7867643962891749
Quick ratio: 0.7867643962891749
Interest coverage ratio: 0.6206398187570799
COGS to revenue (%): 40.85795601369218
SG&A to revenue (%): 5.413685809052839
Free cash flow (dilution-adjusted): -26342000
Buyback yield (%): 0
Retained earnings: -2227350000
Receivables turnover: 2.5630284884775905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1205973814512795
FCF margin (%): -4.66235039664138
Revenue growth (%): -0.9345564977100737
Rule of 40 score: -5.596906894351454
Financial ratios for PDM — quarterly report dated 2025-12-31
Total revenue: 142853000
Gross profit: 84393000
Operating income: 18908000
Net income: -43240000
Capital expenditures: 41428000
Operating cash flow: 50937000
Depreciation & amortization: 58028000
Net tangible assets: 1441710000
Owner earnings: -26640000
Return on net tangible assets (%): -1.8478057306948001
Capex to operating income (%): 219.1030251745293
Buffett classification: The Gruesome
Stock price: 8.34
Shares outstanding: 125019003
Book value: 1496703000
P/B ratio: 0.696636864508189
Market cap (USD): 1042658485.02
Debt to equity: 1.502994248023823
Current ratio: 0.7867643962891749
Quick ratio: 0.7867643962891749
Interest coverage ratio: 0.5834721965068197
COGS to revenue (%): 41.08979160395651
SG&A to revenue (%): 5.220051381490063
Free cash flow (dilution-adjusted): 7072000
Buyback yield (%): 0
Retained earnings: -2227350000
Receivables turnover: 0.6480357466884413
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5047045791236804
FCF margin (%): 4.950543565763407
Revenue growth (%): 2.651566867630045
Rule of 40 score: 7.602110433393452
Financial ratios for PHIA.AS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.738636363636363
Shares outstanding: 971982655
Market cap (USD): 29877421383.806816
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0